Cargando…
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
LINKED ARTICLES: This article is commented on in the editorial by Holford NHG and Anderson BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol 2017; 83: 685–7. doi: 10.1111/bcp.13230 AIM: When different models for weight and age are used in paediatric pharmacokinetic studies it is...
Autores principales: | Germovsek, Eva, Barker, Charlotte I. S., Sharland, Mike, Standing, Joseph F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346879/ https://www.ncbi.nlm.nih.gov/pubmed/27767204 http://dx.doi.org/10.1111/bcp.13160 |
Ejemplares similares
-
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018) -
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018) -
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology()
por: Barker, Charlotte I.S., et al.
Publicado: (2014) -
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE‐3
por: Berger, Rolf M. F., et al.
Publicado: (2017) -
Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
por: Flint, Anne, et al.
Publicado: (2010)